Evidence map›Paper›PMID 24415936›Full record

Trial reportPLoS pathogens2014

IFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children.

Prasanna Jagannathan, Ijeoma Eccles-James, Katherine Bowen, Felistas Nankya, Ann Auma, Samuel Wamala, Charles Ebusu, Mary K Muhindo, Emmanuel Arinaitwe, Jessica Briggs and 5 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 137 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. CD4Nature communications · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Prasanna JagannathanDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Ijeoma Eccles-JamesDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Katherine BowenDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Felistas NankyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Ann AumaInfectious Diseases Research Collaboration, Kampala, Uganda.
Samuel WamalaInfectious Diseases Research Collaboration, Kampala, Uganda.
Charles EbusuInfectious Diseases Research Collaboration, Kampala, Uganda.
Mary K MuhindoInfectious Diseases Research Collaboration, Kampala, Uganda.
Emmanuel ArinaitweInfectious Diseases Research Collaboration, Kampala, Uganda.
Jessica BriggsDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Bryan GreenhouseDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Jordan W TapperoCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Moses R KamyaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Grant DorseyDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Margaret E FeeneyDepartment of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America ; Department of Pediatrics, University of California, San Francisco, San Francisco, California, United States of America.
Infectious Diseases Research Collaboration · UGSan Francisco General Hospital · USCenters for Disease Control and Prevention · USMakerere University · UGUniversity of California, San Francisco · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 1988 to 2026
$93.6M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2010 to 2026
$29.3M
The role of γδ T cells in fetal and infant immune defense against malariaR01AI093615 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2011 to 2025
$9.1M
Mentoring Translational Researchers for Careers in Pediatric Global HealthK24AI113002 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FEENEY, MARGARET E · 2014 to 2023
$1.9M
Immunologic Consequences of Highly Effective Antimalarial ChemopreventionK23AI100949 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAGANNATHAN, PRASANNA · 2012 to 2016
$657k
NCATS NIH HHS UL1 TR000004NIAID NIH HHS K23 AI100949NIAID NIH HHS K24 AI113002NIAID NIH HHS P30 AI027763NIAID NIH HHS P30AI027763NIAID NIH HHS R01 AI093615NIAID NIH HHS R01AI093615NIAID NIH HHS U19 AI089674NIAID NIH HHS U19AI089674PHS HHS U62P024421
6 · The paper itself

Abstract

Although evidence suggests that T cells are critical for immunity to malaria, reliable T cell correlates of exposure to and protection from malaria among children living in endemic areas are lacking. We used multiparameter flow cytometry to perform a detailed functional characterization of malaria-specific T cells in 78 four-year-old children enrolled in a longitudinal cohort study in Tororo, Uganda, a highly malaria-endemic region. More than 1800 episodes of malaria were observed in this cohort, with no cases of severe malaria. We quantified production of IFNγ, TNFα, and IL-10 (alone or in combination) by malaria-specific T cells, and analyzed the relationship of this response to past and future malaria incidence. CD4(+) T cell responses were measurable in nearly all children, with the majority of children having CD4(+) T cells producing both IFNγ and IL-10 in response to malaria-infected red blood cells. Frequencies of IFNγ/IL10 co-producing CD4(+) T cells, which express the Th1 transcription factor T-bet, were significantly higher in children with ≥2 prior episodes/year compared to children with <2 episodes/year (P<0.001) and inversely correlated with duration since malaria (Rho = -0.39, P<0.001). Notably, frequencies of IFNγ/IL10 co-producing cells were not associated with protection from future malaria after controlling for prior malaria incidence. In contrast, children with <2 prior episodes/year were significantly more likely to exhibit antigen-specific production of TNFα without IL-10 (P = 0.003). While TNFα-producing CD4(+) T cells were not independently associated with future protection, the absence of cells producing this inflammatory cytokine was associated with the phenotype of asymptomatic infection. Together these data indicate that the functional phenotype of the malaria-specific T cell response is heavily influenced by malaria exposure intensity, with IFNγ/IL10 co-producing CD4(+) T cells dominating this response among highly exposed children. These CD4(+) T cells may play important modulatory roles in the development of antimalarial immunity.

Indexed as

Immunity, CellularCD4-Positive T-LymphocytesChildChild, PreschoolErythrocytesFemaleHumansInterferon-gammaInterleukin-10MalariaMaleTumor Necrosis Factor-alphaUgandaIFNG protein, humanIL10 protein, humanInterferon-gammaInterleukin-10Tumor Necrosis Factor-alpha

Identifiers

PMID24415936
PMCPMC3887092
OpenAlexW2037345926

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.